Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Poespoprodjo JR"'
Autor:
Leonardo, L, Kenangalem, E, Poespoprodjo, JR, Noviyanti, R, Price, RN, Anstey, NM, Minigo, G, Kho, S
Publikováno v:
Malaria Journal. 21
Background Circulating myeloid-derived-suppressor-cells (MDSC) with immunosuppressive function are increased in human experimental Plasmodium falciparum infection, but have not been studied in clinical malaria. Methods Using flow-cytometry, circulati
Autor:
Studniberg, SI, Ioannidis, LJ, Utami, RAS, Trianty, L, Liao, Y, Abeysekera, W, Li-Wai-Suen, CSN, Pietrzak, HM, Healer, J, Puspitasari, AM, Apriyanti, D, Coutrier, F, Poespoprodjo, JR, Kenangalem, E, Andries, B, Prayoga, P, Sariyanti, N, Smyth, GK, Cowman, AF, Price, RN, Noviyanti, R, Shi, W, Garnham, AL, Hansen, DS
Publikováno v:
Molecular Systems Biology. 18
Clinical immunity to P. falciparum malaria is non-sterilizing, with adults often experiencing asymptomatic infection. Historically, asymptomatic malaria has been viewed as beneficial and required to help maintain clinical immunity. Emerging views sug
Autor:
Ley, B, Alam, MS, Satyagraha, AW, Phru, CS, Thriemer, K, Tadesse, D, Shibiru, T, Hailu, A, Kibria, MG, Hossain, MS, Rahmat, H, Poespoprodjo, JR, Khan, WA, Simpson, JA, Price, RN
Publikováno v:
PLoS neglected tropical diseases. 16(5)
Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the re
Autor:
Setyadi, A, Arguni, E, Kenangalem, E, Hasanuddin, A, Lampah, DA, Thriemer, K, Anstey, NM, Sugiarto, P, Simpson, JA, Price, RN, Douglas, NM, Poespoprodjo, JR
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-11 (2019)
Background: Primaquine (PQ) prevents relapses of vivax malaria but may induce severe haemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient patients. Data on the safety of primaquine in infants are limited. Methods: A retrospective, hospita
Autor:
Poespoprodjo, JR, Kenangalem, E, Douglas, N, Burdam, L, Gdeumana, K, Chalfien, F, Prayoga, P, Thio, F, Devine, A, Marfurt, J, Waramori, G, Yeung, S, Noviyanti, R, Penttinen, P, Bangs, MJ, Sugiarto, P, Simpson, JA, Soenarto, Y, Anstey, NM, Price, RN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::707fdd15798263f1865f8135cdebb917
https://doi.org/10.4269/ajtmh.abstract2019
https://doi.org/10.4269/ajtmh.abstract2019
Autor:
Rahmalia, A, Poespoprodjo, JR, Landuwulang, CU, Ronse, M, Kenangalem, E, Burdam, FH, Ley, B, Price, RN, Thriemer, K, Grietens, KP, Gryseels, C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::7b026b8de1d08784c9c8258bc709c91a
https://doi.org/10.4269/ajtmh.abstract2019
https://doi.org/10.4269/ajtmh.abstract2019
Publikováno v:
JCI Insight
Anemia is a major complication of malaria, driven largely by loss of uninfected RBCs during infection. RBC clearance through loss of complement regulatory proteins (CRPs) is a significant contributor to anemia in Plasmodium falciparum infection, but
Autor:
Thriemer, K, Bobogare, A, Ley, B, Gudo, CS, Alam, MS, Anstey, NM, Ashley, E, Baird, JK, Gryseels, C, Jambert, E, Lacerda, M, Laihad, F, Marfurt, J, Pasaribu, AP, Poespoprodjo, JR, Sutanto, I, Taylor, WR, van den Boogaard, C, Battle, KE, Dysoley, L, Ghimire, P, Hawley, B, Hwang, J, Khan, WA, Mudin, RNB, Sumiwi, ME, Ahmed, R, Aktaruzzaman, MM, Awasthi, KR, Bardaji, A, Bell, D, Boaz, L, Burdam, FH, Chandramohan, D, Cheng, Q, Chindawongsa, K, Culpepper, J, Das, S, Deray, R, Desai, M, Domingo, G, Duoquan, W, Duparc, S, Floranita, R, Gerth-Guyette, E, Howes, RE, Hugo, C, Jagoe, G, Sariwati, E, Jhora, ST, Jinwei, W, Karunajeewa, H, Kenangalem, E, Lal, BK, Landuwulang, C, Le Perru, E, Lee, S-E, Makita, LS, McCarthy, J, Mekuria, A, Mishra, N, Naket, E, Nambanya, S, Nausien, J, Duc, TN, Thi, TN, Noviyanti, R, Pfeffer, D, Qi, G, Rahmalia, A, Rogerson, S, Samad, I, Sattabongkot, J, Satyagraha, A, Shanks, D, Sharma, SN, Sibley, CH, Sungkar, A, Syafruddin, D, Talukdar, A, Tarning, J, Kuile, F, Thapa, S, Theodora, M, Huy, TT, Waramin, E, Waramori, G, Woyessa, A, Wongsrichanalai, C, Xa, NX, Yeom, JS, Hermawan, L, Devine, A, Nowak, S, Jaya, I, Supargiyono, S, Grietens, KP, Price, RN
Publikováno v:
Malaria Journal, Vol 17, Iss 1, Pp 1-7 (2018)
Malaria Journal
Malaria Journal
The goal to eliminate malaria from the Asia-Pacific by 2030 will require the safe and widespread delivery of effective radical cure of malaria. In October 2017, the Asia Pacific Malaria Elimination Network Vivax Working Group met to discuss the imped